This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Exec Summary: Looking ahead into 2025, the UK HealthTech market is on track to continue growing and evolving around four main themes, Apps, Platforms, Data and AI. AI-powered tools are enhancing the accuracy and efficiency of healthcare delivery, leading to improved patient outcomes.
This strategic funding round will accelerate our progress as the leading AI-driven workflow platform in healthcare,” said Doktor Gurson, Co-Founder and CEO at Rad AI. Rad AI is now hiring across a wide range of roles, building a world-class team dedicated to solving some of the most complex challenges in healthcaretechnology.
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year and boy did they deliver.
As we wrap up another year and get ready for 2025 to begin, it is once again time for everyone’s favorite annual tradition of Health IT Predictions! We reached out to our incredible Healthcare IT Today Community to get their insights on what will happen in the coming year and boy did they deliver.
In 2025, HealthTech valuations are expected to continue their upward trajectory, driven by several key factors: 1. Technological Advancements: AI and Machine Learning: AI-powered diagnostics, drug discovery, and personalised medicine are revolutionising healthcare.
Exec Summary: In 2025, Apple's Health Records feature is likely to continue its expansion and integration with various healthcare providers and institutions. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Exec Summary: In 2025, AI Ambient Scribes are poised to make significant strides, reshaping the healthcare landscape. By automating routine tasks, improving accuracy, and enhancing patient care, these technologies have the potential to revolutionise the healthcare industry.
Exec Summary: The HealthTech mergers and acquisitions landscape in 2025, particularly for distressed companies, is shaping up to be a complex and dynamic space, driven by a mix of financial pressures, strategic repositioning, and evolving market demands. By December 2025, expect a bifurcated landscape.
Exec Summary: Merative, formerly known as IBM Watson Health, is gearing up to introduce a range of new products in 2025. With significant investments and a focus on innovation, Merative is poised to play a major role in shaping the future of healthcare data analytics and technology.
Exec Summary As of February 23, 2025, Doximity (NYSE: DOCS), often dubbed the "LinkedIn for Doctors," has shown remarkable strength in the healthcare stock arena, positioning it as a standout performer this year. For the full fiscal year ending March 31, 2025, the company projects revenue between $564.6 million and $565.6
Exec Summary: The HealthTech sector is poised for significant M&A activity in 2025, driven by several key trends: Digital Health Solutions: The increasing demand for digital health solutions to improve healthcare accessibility and efficiency will drive acquisitions of innovative startups and established players in this space.
Nelson Advisors will attend Digital Health Rewired 2025 on March 18-19, 2025, hosted at the NEC Birmingham. Our team of successful healthcaretechnology founders and senior executives have built, pivoted and scaled HealthTech businesses since 2012, securing exits from North American, European and FTSE listed companies.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Exec Summary: The HealthTech M&A landscape in 2025 is characterised by a mix of opportunity and caution. While innovative technologies continue to drive interest, financial discipline and strategic alignment are crucial for successful deals. The increase of distressed company M&A's is a large factor in the 2025 market.
HealthcareTechnology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions. Accessibility: HealthTech can make healthcare more accessible by breaking down barriers such as geography, time, and cost. For example, telemedicine can connect patients with specialists who may be located far away.
While it's impossible to predict every single talking point for the 2025 conference, we can anticipate some key areas of focus based on current industry trends and recent discussions at previous conferences. Here are some likely key talking points for the JP Morgan Annual Healthcare Conference 2025: 1.
Telehealth consultations: Virtual consultations with healthcare providers can improve access to care, especially for people in rural or remote areas. Email lloyd@nelsonadvisors.co.uk Nelson Advisors HealthcareTechnology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions. Subscribe Today!
Nelson Advisors partner Lloyd Price has been invited to Judge the HealthInvestor 2025 Awards for the second year in a row and third time overall for the Nexus Media Group. The Awards evening and presentations will take place on the 4th June 2025 at the Grosvenor House Hotel in London.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.
Exec Summary The four pillars highlight the interconnected nature of the HealthTech ecosystem in 2025. Innovators create new possibilities, Enablers facilitate their implementation, Custodians ensure responsible use, and Arbitrageurs focus on making healthcare more efficient and accessible.
The wound care market is a dynamic and rapidly evolving sector, and 2025 is shaping up to be a pivotal year for innovation and growth in this field. The wound care market is poised for significant growth in 2025 and beyond. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
The NHS's ambition, as part of its upcoming 10-Year Health Plan (expected in spring 2025), is to make this "Neighbourhood Health Service" a cornerstone of reform. HealthcareTechnology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.
Companies with a strong technology moat are typically valued at a premium to those that do not have a moat. Management Team: The experience, track record, and leadership of the management team can be a key factor in valuation. In conclusion, the stage of a company's development is a crucial determinant of its valuation multiple.
For those not familiar, HIMSS is one of the biggest events in health IT, bringing together global healthcare leaders, CIOs, executives, and innovators to discuss the future of healthcaretechnology. With 30,000+ attendees, 1,000+ exhibitors, and hundreds of speakers, its the place to be for the latest in health IT.
For those not familiar, HIMSS is one of the biggest events in health IT, bringing together global healthcare leaders, CIOs, executives, and innovators to discuss the future of healthcaretechnology. With 30,000+ attendees, 1,000+ exhibitors, and hundreds of speakers, its the place to be for the latest in health IT.
Exec Summary: Nelson Advisors Partner Lloyd Price delivered the inaugural talk to the Oxford University MedTech society on Monday 27th January 2025. The Oxford MedTech Society is a vibrant student-led community dedicated to exploring the transformative potential of medical technology. Subscribe Today!
However, its potential to improve clinical decision-making, enhance patient experience, and increase efficiency makes it a valuable tool for healthcare organisations. HealthcareTechnology Thought Leadership from Nelson Advisors Market Insights, Analysis & Predictions.
For those not familiar, HIMSS is one of the biggest events in health IT, bringing together global healthcare leaders, CIOs, executives, and innovators to discuss the future of healthcaretechnology. With 30,000+ attendees, 1,000+ exhibitors, and hundreds of speakers, its the place to be for the latest in health IT.
As a result, interoperability ranks among the top three obstacles to innovation, according to healthcare executives and leaders — with many healthcare organizations still struggling to build infrastructure that enables their technology platforms to easily share information.
The 2025 Tipping Point By March 2025, the pieces are aligning. A startup launching MediSync in 2025, with $20 Million in seed funding (plausible from VCs like Andreessen Horowitz, Index Ventures or Norrsken), could hit $100 Million ARR by 2030, pegging it at a $1 Billion valuation in a frothy HealthTech market.
First Minister John Swinney's speech about improving public services and NHS renewal, given at the National Robotarium in Edinburgh, on Monday 27 January 2025. Email lloyd@nelsonadvisors.co.uk Nelson Advisors HealthcareTechnology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions.
It has the potential to revolutionize healthcare delivery, making it more accessible, convenient, and effective for patients and providers alike. link] HealthcareTechnology Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Visit www.nelsonadvisors.co.uk Visit www.nelsonadvisors.co.uk
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
Grant Thorntons Spring 2024 review flagged renewed activity in specialist care, hinting at a broader trenddistressed deals could comprise 20-30% of HealthTech M&A by year-end 2025, up from quieter periods. The UK HealthTech M&A landscape in 2025 is a tale of distress breeding opportunity.
billon investment of capital in data and technology – from 2025/26 onwards – announced in the Spring Budget will allow us to roll out technology and digital services to improve access, waiting times and outcomes. Modernisation: There's a push to continuously improve core IT systems and remove outdated legacy technology.
Increased Accessibility: DeepSeek R1 can help to make quality healthcare more accessible to people in underserved communities. Email lloyd@nelsonadvisors.co.uk Nelson Advisors HealthcareTechnology Newsletter > Mergers, Acquisitions, Growth, Strategy, Insights & Predictions. Subscribe Today! Subscribe Today!
It's not a cure-all, but it could be a valuable tool in healthcare. Mergers, Acquisitions, Growth and Strategy for HealthcareTechnology companies HealthTech M&A - Buy Side, Sell Side, Growth & Strategy services for companies in Europe, Middle East and Africa. Visit www.nelsonadvisors.co.uk Subscribe Today!
In 2025, B2C2B models are poised to become increasingly prominent in healthcare, driven by several key factors: Digital Health Boom: The rapid growth of digital health technologies, such as telehealth, wearable devices, and AI-powered diagnostics, is creating new opportunities for B2C2B companies to reach both patients and healthcare providers.
Exec Summary: The IPO landscape for HealthTech startups in 2025 is likely to be dynamic, influenced by various factors such as market conditions, company performance, and regulatory changes. Its ability to help patients access quality care and reduce healthcare costs could be a selling point for investors. in funding over 11 rounds. >
IPO Potential: Companies in this space are likely targeting IPOs in 2025. Potential Digital MSK IPO's in 2025 An example of a successful digital MSK IPO is Physitrack, which went public in 2021. Overall, digital MSK is a promising area in healthcaretechnology, and 2025 could be a big year for IPOs in this space.
Nelson Advisors work with HealthcareTechnology Founders, Owners and Investors to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value. HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
As the field continues to develop, it is important to address the ethical and practical challenges associated with this technology. Growth and M&A for HealthcareTechnology companies HealthcareTechnology Thought Leadership from Nelson Advisors – Market Insights, Analysis & Predictions.
For those not familiar, HIMSS is one of the biggest events in health IT, bringing together global healthcare leaders, CIOs, executives, and innovators to discuss the future of healthcaretechnology. With 30,000+ attendees, 1,000+ exhibitors, and hundreds of speakers, its the place to be for the latest in health IT.
About Veradigm Veradigm is a healthcaretechnology company that drives value through its unique combination of platforms, data, expertise, connectivity, and scale. 2025 Veradigm LLC and/or its affiliates. No biopharma or device advertisements appear during the prescribing workflow consistent with applicable law.
We organize all of the trending information in your field so you don't have to. Join 48,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content